Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniela Geba, Johan Mohd Sani, Michaela Gascon, Rebecca Hahn, Kavita Aggarwal & Jinky Rosselli. (2021) Hereditary angioedema patients would prefer newer-generation oral prophylaxis. Journal of Drug Assessment 10:1, pages 51-56.
Read now
Read now
Articles from other publishers (6)
Neehar D. Parikh, Allicia Girvan, Joshua Coulter, Jonathon Gable, Jiat Ling Poon, Sangmi Kim, Anindya Chatterjee & Marco Boeri. (2023) Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference study. BMC Cancer 23:1.
Crossref
Crossref
Junguo Liu, Jinjuan Zhang, Yijun Wang, Guiming Shu, Cheng Lou & Zhi Du. (2022) HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Medicine 101:51, pages e32390.
Crossref
Crossref
Bennet Hensen, Carolin Winkelmann, Frank K. Wacker, Bodo Vogt, Cornelia L. A. Dewald & Thomas Neumann. (2022) Identification of Relevant Attributes for Liver Cancer Therapies (IRALCT): a maximum-difference-scaling analysis. Scientific Reports 12:1.
Crossref
Crossref
Yuan Wan, Bin Chen, Nan Li, Jian-Yong Yang, Hai-Tao Dai, Ke-Yu Tang, Chun-Yong Wen & Yong-Hui Huang. (2022) Transradial versus Transfemoral Access for Patients with Liver Cancer Undergoing Hepatic Arterial Infusion Chemotherapy: Patient Experience and Procedural Complications. Journal of Vascular and Interventional Radiology 33:8, pages 956-963.e1.
Crossref
Crossref
Siu Hing Lo, Rohini Sharma, Charlotte E Costentin, Daniel Aggio, Suki Shergill, Fabien Colaone, Victoria K Brennan, Vincenzo A Straccia, Ion Agirrezabal & Andrew J Lloyd. (2021) Patient preferences for advanced hepatocellular carcinoma treatment: a multicountry stated preference study. Future Oncology 17:32, pages 4275-4287.
Crossref
Crossref
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang & Xiaoyu Li. (2021) Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref